Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
Well, they can do Anavex math just like | jav0033 | investorshub | 04/25/2024 12:43:46 PM |
We need to get real and to recognize | nidan7500 | investorshub | 04/25/2024 12:27:00 PM |
After 10,000 straight posts telling everybody that Avxl | tootalljones | investorshub | 04/25/2024 12:13:26 PM |
sum, when it was formed 5 years ago | powerwalker | investorshub | 04/25/2024 11:37:45 AM |
Miss Cleo ;-) Seeing the Fib energies? | frrol | investorshub | 04/25/2024 10:49:42 AM |
It is rare I sell and even rarer | Investor2014 | investorshub | 04/25/2024 10:26:03 AM |
Based on what? | Guzzi62 | investorshub | 04/25/2024 6:33:06 AM |
Submission is MILLIONS AND MILLIONS of pages according | crescentmotor | investorshub | 04/25/2024 5:34:20 AM |
Chances of submission to the EMA is close | crescentmotor | investorshub | 04/25/2024 5:28:09 AM |
Im not sure what trial results you are | ignatiusrielly35 | investorshub | 04/25/2024 3:09:24 AM |
Exactly. Nailed it. | ignatiusrielly35 | investorshub | 04/25/2024 3:07:34 AM |
Anavex 3-71 (formerly known as AF710b) | georgejjl | investorshub | 04/25/2024 2:51:55 AM |
Yep, I like the 2.90 target. And | 123tom | investorshub | 04/25/2024 2:50:24 AM |
Couldn't agree more. I did, however, buy more | kspar1 | investorshub | 04/25/2024 2:34:22 AM |
Thanks . | catdaddy | investorshub | 04/25/2024 2:24:22 AM |
Submission is MILLIONS AND MILLIONS of pages according | jav0033 | investorshub | 04/25/2024 2:18:59 AM |
@Catdaddy, ... as far as maintaining my | 123tom | investorshub | 04/25/2024 2:18:10 AM |
Missing has succeeded in my developing a contrarian | Reyeton | investorshub | 04/25/2024 2:17:59 AM |
Amazing isnt it, 52 week low sitting on | tredenwater2 | investorshub | 04/25/2024 2:16:22 AM |
$2.90 it is next bottom support. | jav0033 | investorshub | 04/25/2024 2:14:23 AM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
LOS ANGELES, April 23, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
LOS ANGELES, April 16, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceu...